Walgreens Boots Alliance, Inc. Logo

Walgreens Boots Alliance, Inc.

0LSZ.L

(0.0)
Stock Price

8,54 USD

-10.7% ROA

-34.89% ROE

-1.35x PER

Market Cap.

7.838.537.000,00 USD

83.33% DER

13.55% Yield

-3.99% NPM

Walgreens Boots Alliance, Inc. Stock Analysis

Walgreens Boots Alliance, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Walgreens Boots Alliance, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Walgreens Boots Alliance, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Walgreens Boots Alliance, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Walgreens Boots Alliance, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Walgreens Boots Alliance, Inc. Revenue
Year Revenue Growth
1985 3.161.900.000
1986 3.660.600.000 13.62%
1987 4.281.600.000 14.5%
1988 4.883.500.000 12.33%
1989 5.380.100.000 9.23%
1990 6.047.500.000 11.04%
1991 6.733.000.000 10.18%
1992 7.475.000.000 9.93%
1993 8.294.800.000 9.88%
1994 9.235.000.000 10.18%
1995 10.395.100.000 11.16%
1996 11.778.400.000 11.74%
1997 13.363.000.000 11.86%
1998 15.307.000.000 12.7%
1999 17.838.800.000 14.19%
2000 21.206.900.000 15.88%
2001 24.623.000.000 13.87%
2002 28.681.100.000 14.15%
2003 32.505.400.000 11.77%
2004 37.508.200.000 13.34%
2005 42.201.600.000 11.12%
2006 47.409.000.000 10.98%
2007 53.762.000.000 11.82%
2008 59.034.300.000 8.93%
2009 63.335.000.000 6.79%
2010 67.420.000.000 6.06%
2011 72.184.000.000 6.6%
2012 71.633.000.000 -0.77%
2013 72.217.000.000 0.81%
2014 76.392.000.000 5.47%
2015 103.444.000.000 26.15%
2016 117.351.000.000 11.85%
2017 118.214.000.000 0.73%
2018 131.537.000.000 10.13%
2019 136.866.000.000 3.89%
2020 139.537.000.000 1.91%
2021 132.509.000.000 -5.3%
2022 132.703.000.000 0.15%
2023 139.081.000.000 4.59%
2024 145.404.000.000 4.35%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Walgreens Boots Alliance, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 105.000.000 100%
2014 127.000.000 17.32%
2015 178.000.000 28.65%
2016 238.000.000 25.21%
2017 245.000.000 2.86%
2018 254.000.000 3.54%
2019 260.000.000 2.31%
2020 300.000.000 13.33%
2021 284.000.000 -5.63%
2022 307.000.000 7.49%
2023 371.000.000 17.25%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Walgreens Boots Alliance, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 17.257.000.000 100%
2014 17.727.000.000 2.65%
2015 22.571.000.000 21.46%
2016 23.910.000.000 5.6%
2017 23.740.000.000 -0.72%
2018 24.569.000.000 3.37%
2019 24.660.000.000 0.37%
2020 26.513.000.000 6.99%
2021 23.814.000.000 -11.33%
2022 26.433.000.000 9.91%
2023 33.430.000.000 20.93%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Walgreens Boots Alliance, Inc. EBITDA
Year EBITDA Growth
1985 210.400.000
1986 238.400.000 11.74%
1987 263.300.000 9.46%
1988 279.100.000 5.66%
1989 308.100.000 9.41%
1990 339.000.000 9.12%
1991 396.500.000 14.5%
1992 440.400.000 9.97%
1993 510.800.000 13.78%
1994 568.400.000 10.13%
1995 646.700.000 12.11%
1996 746.300.000 13.35%
1997 866.000.000 13.82%
1998 987.000.000 12.26%
1999 1.225.500.000 19.46%
2000 1.420.700.000 13.74%
2001 1.645.400.000 13.66%
2002 1.925.300.000 14.54%
2003 2.164.800.000 11.06%
2004 2.529.500.000 14.42%
2005 2.906.100.000 12.96%
2006 3.273.700.000 11.23%
2007 3.826.600.000 14.45%
2008 4.280.700.000 10.61%
2009 4.222.000.000 -1.39%
2010 4.488.000.000 5.93%
2011 5.451.000.000 17.67%
2012 4.630.000.000 -17.73%
2013 5.323.000.000 13.02%
2014 5.029.000.000 -5.85%
2015 7.658.000.000 34.33%
2016 7.458.000.000 -2.68%
2017 7.200.000.000 -3.58%
2018 8.361.000.000 13.89%
2019 7.269.000.000 -15.02%
2020 3.309.000.000 -119.67%
2021 5.454.000.000 39.33%
2022 6.375.000.000 14.45%
2023 -2.582.000.000 346.9%
2024 2.872.000.000 189.9%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Walgreens Boots Alliance, Inc. Gross Profit
Year Gross Profit Growth
1985 1.003.900.000
1986 1.154.400.000 13.04%
1987 1.334.300.000 13.48%
1988 1.473.900.000 9.47%
1989 1.595.400.000 7.62%
1990 1.761.500.000 9.43%
1991 1.988.200.000 11.4%
1992 2.189.400.000 9.19%
1993 2.440.500.000 10.29%
1994 2.738.700.000 10.89%
1995 3.044.300.000 10.04%
1996 3.410.900.000 10.75%
1997 3.845.000.000 11.29%
1998 4.356.000.000 11.73%
1999 5.070.300.000 14.09%
2000 5.971.100.000 15.09%
2001 6.574.100.000 9.17%
2002 7.605.000.000 13.56%
2003 8.799.200.000 13.57%
2004 10.197.800.000 13.71%
2005 11.787.800.000 13.49%
2006 13.168.600.000 10.49%
2007 15.243.900.000 13.61%
2008 16.643.200.000 8.41%
2009 17.613.000.000 5.51%
2010 18.976.000.000 7.18%
2011 20.492.000.000 7.4%
2012 20.342.000.000 -0.74%
2013 21.119.000.000 3.68%
2014 21.569.000.000 2.09%
2015 26.924.000.000 19.89%
2016 29.874.000.000 9.87%
2017 29.162.000.000 -2.44%
2018 30.792.000.000 5.29%
2019 30.076.000.000 -2.38%
2020 28.017.000.000 -7.35%
2021 28.067.000.000 0.18%
2022 28.266.000.000 0.7%
2023 27.072.000.000 -4.41%
2024 25.836.000.000 -4.78%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Walgreens Boots Alliance, Inc. Net Profit
Year Net Profit Growth
1985 94.200.000
1986 103.100.000 8.63%
1987 103.500.000 0.39%
1988 129.100.000 19.83%
1989 154.200.000 16.28%
1990 174.600.000 11.68%
1991 195.000.000 10.46%
1992 220.600.000 11.6%
1993 221.700.000 0.5%
1994 281.900.000 21.36%
1995 320.800.000 12.13%
1996 371.700.000 13.69%
1997 436.000.000 14.75%
1998 511.000.000 14.68%
1999 624.100.000 18.12%
2000 776.900.000 19.67%
2001 885.600.000 12.27%
2002 1.019.200.000 13.11%
2003 1.175.700.000 13.31%
2004 1.360.200.000 13.56%
2005 1.559.500.000 12.78%
2006 1.750.600.000 10.92%
2007 2.041.300.000 14.24%
2008 2.156.700.000 5.35%
2009 2.006.000.000 -7.51%
2010 2.091.000.000 4.07%
2011 2.714.000.000 22.96%
2012 2.127.000.000 -27.6%
2013 2.450.000.000 13.18%
2014 1.932.000.000 -26.81%
2015 4.220.000.000 54.22%
2016 4.173.000.000 -1.13%
2017 4.078.000.000 -2.33%
2018 5.024.000.000 18.83%
2019 3.982.000.000 -26.17%
2020 456.000.000 -773.25%
2021 1.328.000.000 65.66%
2022 4.337.000.000 69.38%
2023 -3.080.000.000 240.81%
2024 1.376.000.000 323.84%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Walgreens Boots Alliance, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 1 0%
2000 1 0%
2001 1 0%
2002 1 100%
2003 1 0%
2004 1 0%
2005 2 0%
2006 2 0%
2007 2 50%
2008 2 0%
2009 2 0%
2010 2 0%
2011 3 0%
2012 2 0%
2013 3 0%
2014 2 0%
2015 4 50%
2016 4 -33.33%
2017 4 0%
2018 5 40%
2019 4 -25%
2020 1 0%
2021 2 100%
2022 5 80%
2023 -4 266.67%
2024 2 400%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Walgreens Boots Alliance, Inc. Free Cashflow
Year Free Cashflow Growth
1989 62.100.000
1990 47.400.000 -31.01%
1991 9.900.000 -378.79%
1992 193.000.000 94.87%
1993 122.200.000 -57.94%
1994 65.400.000 -86.85%
1995 34.700.000 -88.47%
1996 46.700.000 25.7%
1997 165.000.000 71.7%
1998 -70.000.000 335.71%
1999 -71.100.000 1.55%
2000 -147.400.000 51.76%
2001 -517.800.000 71.53%
2002 539.400.000 196%
2003 696.400.000 22.54%
2004 713.200.000 2.36%
2005 133.700.000 -433.43%
2006 1.101.800.000 87.87%
2007 571.400.000 -92.82%
2008 814.000.000 29.8%
2009 2.184.000.000 62.73%
2010 2.730.000.000 20%
2011 2.430.000.000 -12.35%
2012 2.881.000.000 15.65%
2013 3.089.000.000 6.73%
2014 2.787.000.000 -10.84%
2015 4.413.000.000 36.85%
2016 6.522.000.000 32.34%
2017 5.900.000.000 -10.54%
2018 6.898.000.000 14.47%
2019 3.892.000.000 -77.24%
2020 4.110.000.000 5.3%
2021 4.176.000.000 1.58%
2022 2.165.000.000 -92.89%
2023 141.000.000 -1435.46%
2024 327.000.000 56.88%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Walgreens Boots Alliance, Inc. Operating Cashflow
Year Operating Cashflow Growth
1989 183.400.000
1990 239.100.000 23.3%
1991 212.400.000 -12.57%
1992 337.900.000 37.14%
1993 306.900.000 -10.1%
1994 355.400.000 13.65%
1995 345.000.000 -3.01%
1996 411.300.000 16.12%
1997 650.000.000 36.72%
1998 571.000.000 -13.84%
1999 625.200.000 8.67%
2000 971.700.000 35.66%
2001 719.200.000 -35.11%
2002 1.473.800.000 51.2%
2003 1.491.500.000 1.19%
2004 1.652.700.000 9.75%
2005 1.371.200.000 -20.53%
2006 2.439.600.000 43.79%
2007 2.356.700.000 -3.52%
2008 3.039.000.000 22.45%
2009 4.111.000.000 26.08%
2010 3.744.000.000 -9.8%
2011 3.643.000.000 -2.77%
2012 4.431.000.000 17.78%
2013 4.301.000.000 -3.02%
2014 3.893.000.000 -10.48%
2015 5.664.000.000 31.27%
2016 7.847.000.000 27.82%
2017 7.251.000.000 -8.22%
2018 8.265.000.000 12.27%
2019 5.594.000.000 -47.75%
2020 5.484.000.000 -2.01%
2021 5.555.000.000 1.28%
2022 3.899.000.000 -42.47%
2023 2.258.000.000 -72.67%
2024 604.000.000 -273.84%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Walgreens Boots Alliance, Inc. Capital Expenditure
Year Capital Expenditure Growth
1989 121.300.000
1990 191.700.000 36.72%
1991 202.500.000 5.33%
1992 144.900.000 -39.75%
1993 184.700.000 21.55%
1994 290.000.000 36.31%
1995 310.300.000 6.54%
1996 364.600.000 14.89%
1997 485.000.000 24.82%
1998 641.000.000 24.34%
1999 696.300.000 7.94%
2000 1.119.100.000 37.78%
2001 1.237.000.000 9.53%
2002 934.400.000 -32.38%
2003 795.100.000 -17.52%
2004 939.500.000 15.37%
2005 1.237.500.000 24.08%
2006 1.337.800.000 7.5%
2007 1.785.300.000 25.07%
2008 2.225.000.000 19.76%
2009 1.927.000.000 -15.46%
2010 1.014.000.000 -90.04%
2011 1.213.000.000 16.41%
2012 1.550.000.000 21.74%
2013 1.212.000.000 -27.89%
2014 1.106.000.000 -9.58%
2015 1.251.000.000 11.59%
2016 1.325.000.000 5.58%
2017 1.351.000.000 1.92%
2018 1.367.000.000 1.17%
2019 1.702.000.000 19.68%
2020 1.374.000.000 -23.87%
2021 1.379.000.000 0.36%
2022 1.734.000.000 20.47%
2023 2.117.000.000 18.09%
2024 277.000.000 -664.26%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Walgreens Boots Alliance, Inc. Equity
Year Equity Growth
1985 481.000.000
1986 553.600.000 13.11%
1987 622.300.000 11.04%
1988 712.600.000 12.67%
1989 823.400.000 13.46%
1990 947.300.000 13.08%
1991 1.081.200.000 12.38%
1992 1.233.300.000 12.33%
1993 1.378.800.000 10.55%
1994 1.573.600.000 12.38%
1995 1.792.600.000 12.22%
1996 2.043.100.000 12.26%
1997 2.373.000.000 13.9%
1998 2.849.000.000 16.71%
1999 3.484.300.000 18.23%
2000 4.234.000.000 17.71%
2001 5.207.200.000 18.69%
2002 6.230.200.000 16.42%
2003 7.195.700.000 13.42%
2004 8.228.000.000 12.55%
2005 8.889.700.000 7.44%
2006 10.115.800.000 12.12%
2007 11.104.300.000 8.9%
2008 12.869.400.000 13.72%
2009 14.376.000.000 10.48%
2010 14.400.000.000 0.17%
2011 14.847.000.000 3.01%
2012 18.236.000.000 18.58%
2013 19.454.000.000 6.26%
2014 20.665.000.000 5.86%
2015 31.739.000.000 34.89%
2016 30.682.000.000 -3.45%
2017 29.082.000.000 -5.5%
2018 27.371.000.000 -6.25%
2019 24.793.000.000 -10.4%
2020 21.634.000.000 -14.6%
2021 24.224.000.000 10.69%
2022 30.408.000.000 20.34%
2023 28.490.000.000 -6.73%
2024 15.430.000.000 -84.64%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Walgreens Boots Alliance, Inc. Assets
Year Assets Growth
1985 961.900.000
1986 1.197.100.000 19.65%
1987 1.361.900.000 12.1%
1988 1.511.900.000 9.92%
1989 1.681.100.000 10.06%
1990 1.913.600.000 12.15%
1991 2.094.600.000 8.64%
1992 2.373.600.000 11.75%
1993 2.535.200.000 6.37%
1994 2.908.700.000 12.84%
1995 3.252.600.000 10.57%
1996 3.633.600.000 10.49%
1997 4.207.000.000 13.63%
1998 4.902.000.000 14.18%
1999 5.906.700.000 17.01%
2000 7.103.700.000 16.85%
2001 8.833.800.000 19.59%
2002 9.878.800.000 10.58%
2003 11.405.900.000 13.39%
2004 13.342.100.000 14.51%
2005 14.608.800.000 8.67%
2006 17.131.100.000 14.72%
2007 19.313.600.000 11.3%
2008 22.410.200.000 13.82%
2009 25.142.000.000 10.87%
2010 26.275.000.000 4.31%
2011 27.454.000.000 4.29%
2012 33.462.000.000 17.95%
2013 35.481.000.000 5.69%
2014 37.182.000.000 4.57%
2015 68.782.000.000 45.94%
2016 72.688.000.000 5.37%
2017 66.009.000.000 -10.12%
2018 68.124.000.000 3.1%
2019 68.239.000.000 0.17%
2020 87.174.000.000 21.72%
2021 81.285.000.000 -7.24%
2022 90.124.000.000 9.81%
2023 96.628.000.000 6.73%
2024 82.985.000.000 -16.44%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Walgreens Boots Alliance, Inc. Liabilities
Year Liabilities Growth
1985 480.900.000
1986 643.500.000 25.27%
1987 739.600.000 12.99%
1988 799.300.000 7.47%
1989 857.700.000 6.81%
1990 966.300.000 11.24%
1991 1.013.400.000 4.65%
1992 1.140.300.000 11.13%
1993 1.156.400.000 1.39%
1994 1.335.100.000 13.38%
1995 1.460.000.000 8.55%
1996 1.590.500.000 8.2%
1997 1.834.000.000 13.28%
1998 2.053.000.000 10.67%
1999 2.422.400.000 15.25%
2000 2.869.700.000 15.59%
2001 3.626.600.000 20.87%
2002 3.648.600.000 0.6%
2003 4.210.200.000 13.34%
2004 5.114.100.000 17.67%
2005 5.719.100.000 10.58%
2006 7.015.300.000 18.48%
2007 8.209.300.000 14.54%
2008 9.540.800.000 13.96%
2009 10.766.000.000 11.38%
2010 11.875.000.000 9.34%
2011 12.607.000.000 5.81%
2012 15.226.000.000 17.2%
2013 16.027.000.000 5%
2014 16.621.000.000 3.57%
2015 37.482.000.000 55.66%
2016 42.407.000.000 11.61%
2017 37.735.000.000 -12.38%
2018 41.435.000.000 8.93%
2019 43.446.000.000 4.63%
2020 66.038.000.000 34.21%
2021 57.463.000.000 -14.92%
2022 59.716.000.000 3.77%
2023 68.138.000.000 12.36%
2024 67.555.000.000 -0.86%

Walgreens Boots Alliance, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
168.62
Net Income per Share
-6.73
Price to Earning Ratio
-1.35x
Price To Sales Ratio
0.05x
POCF Ratio
10.81
PFCF Ratio
-8.77
Price to Book Ratio
0.57
EV to Sales
0.28
EV Over EBITDA
-3.75
EV to Operating CashFlow
56.28
EV to FreeCashFlow
-45.64
Earnings Yield
-0.74
FreeCashFlow Yield
-0.11
Market Cap
7,84 Bil.
Enterprise Value
40,80 Bil.
Graham Number
48.93
Graham NetNet
-67.31

Income Statement Metrics

Net Income per Share
-6.73
Income Quality
-0.12
ROE
-0.31
Return On Assets
-0.07
Return On Capital Employed
0.01
Net Income per EBT
0.43
EBT Per Ebit
-29.75
Ebit per Revenue
0
Effective Tax Rate
0.07

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.17
Operating Profit Margin
0
Pretax Profit Margin
-0.09
Net Profit Margin
-0.04

Dividends

Dividend Yield
0.14
Dividend Yield %
13.55
Payout Ratio
-0.25
Dividend Per Share
1.23

Operating Metrics

Operating Cashflow per Share
0.84
Free CashFlow per Share
-1.04
Capex to Operating CashFlow
2.23
Capex to Revenue
0.01
Capex to Depreciation
0.66
Return on Invested Capital
-0.5
Return on Tangible Assets
-0.11
Days Sales Outstanding
14.92
Days Payables Outstanding
40.25
Days of Inventory on Hand
26.36
Receivables Turnover
24.46
Payables Turnover
9.07
Inventory Turnover
13.85
Capex per Share
1.88

Balance Sheet

Cash per Share
0,82
Book Value per Share
17,88
Tangible Book Value per Share
-15.32
Shareholders Equity per Share
15.81
Interest Debt per Share
13.76
Debt to Equity
0.83
Debt to Assets
0.14
Net Debt to EBITDA
-3.03
Current Ratio
0.65
Tangible Asset Value
-13,23 Bil.
Net Current Asset Value
-51,22 Bil.
Invested Capital
50931000000
Working Capital
-8,70 Bil.
Intangibles to Total Assets
0.35
Average Receivables
6,07 Bil.
Average Payables
12,94 Bil.
Average Inventory
8567500000
Debt to Market Cap
1.45

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Walgreens Boots Alliance, Inc. Dividends
Year Dividends Growth
2018 1
2023 2 100%
2024 1 0%

Walgreens Boots Alliance, Inc. Profile

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

CEO
Mr. Timothy C. Wentworth
Employee
206.000
Address
108 Wilmot Road
Deerfield, 60015

Walgreens Boots Alliance, Inc. Executives & BODs

Walgreens Boots Alliance, Inc. Executives & BODs
# Name Age
1 Ms. Ornella Barra
Chief Operating Officer of International
70
2 Ms. Lanesha T. Minnix
Executive Vice President & Global Chief Legal Officer
70
3 Mr. Matthew D'Ambrosio
Senior Vice President and Global Chief Compliance & Ethics Officer
70
4 Mr. Stefano Pessina
Executive Chairman of the Board
70
5 Mr. Todd D. Heckman
Senior Vice President, Global Controller & Chief Accounting Officer
70
6 Mr. Timothy C. Wentworth
Chief Executive Officer & Director
70
7 Dr. Neal Joseph Sample Ph.D.
Executive Vice President & Chief Information Officer
70
8 Ms. Elizabeth L. Burger
Executive Vice President & Chief Human Resources Officer
70
9 Ms. Tiffany Ann Kanaga
Vice President of Global Investor Relations
70
10 Mr. Manmohan Mahajan
Executive Vice President & Global Chief Financial Officer
70

Walgreens Boots Alliance, Inc. Competitors